Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na+/Ca2+ exchanger and regulates their functional activity

Journal of Biological Chemistry

Volumn 289, Issue 11, 2014, Pages 7470-7482

  Brustovetsky, Tatiana ^a   Pellman, Jessica J ^a   Yang, Xiao Fang ^a,b   Khanna, Rajesh ^a,b   Brustovetsky, Nickolay ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; EXPERIMENTS; PEPTIDES; SODIUM;

CO-IMMUNOPRECIPITATION EXPERIMENTS; DOWN-REGULATION; FUNCTIONAL ACTIVITIES; IMMUNOPRECIPITATIONS; MECHANISM OF ACTION; N METHYL D ASPARTATE RECEPTOR; N-METHYL-D-ASPARTATE; SHORT INTERFERING RNA (SIRNA);

CALCIUM;

CALCIUM ION; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; GLUTAMIC ACID; IONOMYCIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SMALL INTERFERING RNA; SODIUM CALCIUM EXCHANGE PROTEIN; TAT CBD3 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM DYSREGULATION; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL MEMBRANE; COMPLEX FORMATION; CRMP2 GENE; ELECTROLYTE DISTURBANCE; GENE EXPRESSION REGULATION; GENE SILENCING; IMMUNOPRECIPITATION; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RAT; REGULATORY MECHANISM;

CALCIUM SIGNALING; CRMP2; GLUTAMATE; GLUTAMATE RECEPTORS; NEURONS; NMDA RECEPTOR; SODIUM CALCIUM EXCHANGE; TAT-CBD3;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; CYTOSOL; ELECTROPHYSIOLOGY; GENE EXPRESSION REGULATION; GLUTAMIC ACID; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; HOMEOSTASIS; N-METHYLASPARTATE; NERVE TISSUE PROTEINS; NEURONS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SODIUM-CALCIUM EXCHANGER;

EID: 84896267792     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.518472     Document Type: Article

References (50)

1. Mattson, M. P. (2003) Excitotoxic and excitoprotective mechanisms. Abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med. 3, 65-94
2. Salińska, E., Danysz, W., and Łazarewicz, J. W. (2005) The role of excitotoxicity in neurodegeneration. Folia Neuropathol. 43, 322-339
3. 2+ exchanger in excitotoxicity. Cell 120, 275-285
4. Farooqui, A. A., Ong, W. Y., and Horrocks, L. A. (2006) Inhibitors of brain phospholipase A2 activity. Their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol. Rev. 58, 591-620 (Pubitemid 44403685)
5. 2+ exchanger degradation occur downstream of calcium deregulation in hippocampal neurons exposed to excitotoxic glutamate. J. Neurosci. Res. 88, 1317-1328
6. 2+ influx elicited by glutamate. Role in neuronal death. Mol. Pharmacol. 36, 106-112
7. Thayer, S. A., and Miller, R. J. (1990) Regulation of the intracellular free calcium concentration in single rat dorsal root ganglion neurones in vitro. J. Physiol. 425, 85-115 (Pubitemid 20191661)
8. Budd, S. L., and Nicholls, D. G. (1996) Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurochem. 67, 2282-2291 (Pubitemid 26392497)
9. Tymianski, M., Charlton, M. P., Carlen, P. L., and Tator, C. H. (1993) Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J. Neurosci. 13, 2085-2104 (Pubitemid 23113418)
10. 2+ concentration increases in cultured rat forebrain neurons. Mol. Pharmacol. 53, 742-749
11. +. Mol. Pharmacol. 56, 619-632
12. 2+ exchanger. Neurobiol. Dis. 46, 109-117
13. Schmidt, E. F., and Strittmatter, S. M. (2007) The CRMP family of proteins and their role in Sema3A signaling. Adv. Exp. Med. Biol. 600, 1-11
14. Hensley, K., Venkova, K., Christov, A., Gunning, W., and Park, J. (2011) Collapsin response mediator protein-2. An emerging pathologic feature and therapeutic target for neurodisease indications. Mol. Neurobiol. 43, 180-191
15. Khanna, R., Wilson, S. M., Brittain, J. M., Weimer, J., Sultana, R., Butterfield, A., and Hensley, K. (2012) Opening Pandora's jar. A primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders. Future Neurol. 7, 749-771
16. Brittain, J. M., Chen, L., Wilson, S. M., Brustovetsky, T., Gao, X., Ashpole, N. M., Molosh, A. I., You, H., Hudmon, A., Shekhar, A., White, F. A., Zamponi, G. W., Brustovetsky, N., Chen, J., and Khanna, R. (2011) Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2). J. Biol. Chem. 286, 37778-37792
17. Dubinsky, J. M. (1993) Intracellular calcium levels during the period of delayed excitotoxicity. J. Neurosci. 13, 623-631
18. 2+ loads by mitochondria in cultured rat hippocampal neurons. J. Neurophysiol. 76, 1611-1621
19. White, R. J., and Reynolds, I. J. (1996) Mitochondrial depolarization in glutamate-stimulated neurons. An early signal specific to excitotoxin exposure. J. Neurosci. 16, 5688-5697 (Pubitemid 26293392)
20. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450
21. 2+ loading in dendrites and somata of CA1 neurons in acute slice. Hippocampus 17, 1049-1059
22. Stanika, R. I., Pivovarova, N. B., Brantner, C. A., Watts, C. A., Winters, C. A., and Andrews, S. B. (2009) Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc. Natl. Acad. Sci. U.S.A. 106, 9854-9859
23. 2+ exchanger, blocks N-methyl-D-aspartate receptor and inhibits mitochondrial complex I. Br. J. Pharmacol. 162, 255-270
24. 2+ exchanger expression and function in a rabbit model of myocardial infarction. J. Cardiovasc. Electrophysiol. 17, S57-S63
25. Morris, R. G., Anderson, E., Lynch, G. S., and Baudry, M. (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774-776 (Pubitemid 16145031)
26. Al-Hallaq, R. A., Conrads, T. P., Veenstra, T. D., and Wenthold, R. J. (2007) NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus. J. Neurosci. 27, 8334-8343 (Pubitemid 47219608)
27. Zhou, M., and Baudry, M. (2006) Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. J. Neurosci. 26, 2956-2963
28. Liu, Y., Wong, T. P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T. W., Wu, D. C., Lu, J., Tymianski, M., Craig, A. M., and Wang, Y. T. (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846-2857 (Pubitemid 46438991)
29. Hallett, P. J., Spoelgen, R., Hyman, B. T., Standaert, D. G., and Dunah, A. W. (2006) Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking. J. Neurosci. 26, 4690-4700 (Pubitemid 44315370)
30. 2+ exchanger in neurons. Neuropharmacology 63, 974-982
31. Piekarz, A. D., Due, M. R., Khanna, M., Wang, B., Ripsch, M. S., Wang, R., Meroueh, S. O., Vasko, M. R., White, F. A., and Khanna, R. (2012) CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy. Mol. Pain 8, 54
32. Kimura, J., Noma, A., and Irisawa, H. (1986) Na-Ca exchange current in mammalian heart cells. Nature 319, 596-597 (Pubitemid 16110949)
33. Mechmann, S., and Pott, L. (1986) Identification of Na-Ca exchange current in single cardiac myocytes. Nature 319, 597-599 (Pubitemid 16110950)
34. 2+ exchange current elicited from isolated rabbit ventricular myocytes by voltage ramp and step protocols. Pflugers Arch. 437, 944-954
35. Brittain, J. M., Duarte, D. B., Wilson, S. M., Zhu, W., Ballard, C., Johnson, P. L., Liu, N., Xiong, W., Ripsch, M. S., Wang, Y., Fehrenbacher, J. C., Fitz, S. D., Khanna, M., Park, C. K., Schmutzler, B. S., Cheon, B. M., Due, M. R., Brustovetsky, T., Ashpole, N. M., Hudmon, A., Meroueh, S. O., Hingtgen, C. M., Brustovetsky, N., Ji, R. R., Hurley, J. H., Jin, X., Shekhar, A., Xu, X. M., Oxford, G. S., Vasko, M. R., White, F. A., and Khanna, R. (2011) Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca(2) channel complex. Nat. Med. 17, 822-829
36. 2+ exchanger. From molecular biology to therapeutic perspectives. Pharmacol. Rev. 56, 633-654
37. 2+-dependent mitochondrial contraction. Cell Calcium 46, 18-29
38. Li, V., Brustovetsky, T., and Brustovetsky, N. (2009) Role of cyclophilin D-dependent mitochondrial permeability transition in glutamate-induced calcium deregulation and excitotoxic neuronal death. Exp. Neurol. 218, 171-182
39. Chalmers, S., and Nicholls, D. G. (2003) The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria. J. Biol. Chem. 278, 19062-19070 (Pubitemid 36799293)
40. Bernardi, P. (1999) Mitochondrial transport of cations. Channels, exchangers, and permeability transition. Physiol. Rev. 79, 1127-1155
41. 2+ exchangers and contributes to NMDA excitotoxicity. J. Neurochem. 83, 1321-1328
42. Bretin, S., Rogemond, V., Marin, P., Maus, M., Torrens, Y., Honnorat, J., Glowinski, J., Prémont, J., and Gauchy, C. (2006) Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. J. Neurochem. 98, 1252-1265 (Pubitemid 44127799)
43. Kowara, R., Chen, Q., Milliken, M., and Chakravarthy, B. (2005) Calpain-mediated truncation of dihydropyrimidinase-like 3 protein (DPYSL3) in response to NMDA and H2O2 toxicity. J. Neurochem. 95, 466-474 (Pubitemid 41457515)
44. Liu, W., Zhou, X. W., Liu, S., Hu, K., Wang, C., He, Q., and Li, M. (2009) Calpain-truncated CRMP-3 and -4 contribute to potassium deprivation-induced apoptosis of cerebellar granule neurons. Proteomics 9, 3712-3728
45. Brittain, J. M., Piekarz, A. D., Wang, Y., Kondo, T., Cummins, T. R., and Khanna, R. (2009) An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J. Biol. Chem. 284, 31375-31390
46. Feldman, P., and Khanna, R. (2013) Challenging the catechism of therapeutics for chronic neuropathic pain. Targeting CaV2.2 interactions with CRMP2 peptides. Neurosci. Lett. 557, 27-36
47. Ju, W., Li, Q., Allette, Y. M., Ripsch, M. S., White, F. A., and Khanna, R. (2013) Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide. J. Neurochem. 124, 869-879
48. Brittain, J. M., Wang, Y., Eruvwetere, O., and Khanna, R. (2012) Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2. FEBS Lett. 586, 3813-3818
49. 2+ channel peptides. J. Biol. Chem. 287, 35065-35077
50. Kiedrowski, L., Brooker, G., Costa, E., and Wroblewski, J. T. (1994) Glutamate impairs neuronal calcium extrusion while reducing sodium gradient. Neuron 12, 295-300 (Pubitemid 24071295)